Intermediate Name | CAS No |
|---|---|
3-Bromo-5-tertbutyl phenyl boronic acid | 1373881-94-7 |
Dimethylphosphoramidic dichloride | 677-43-0 |
N-1,3-Benzodioxol-5-yl-2,2,2-trifluoroacetamide | 85575-56-0 |
5-Amino-1-methyl-2-oxoindoline | 20870-91-1 |
4-(4-Nitrophenoxy)aniline | 6149-33-3 |
Cryptand 222 (Kryptofix 222) | 23978-09-8 |
1-(1,1-Dimethylethyl) 2-ethyl (2R,5S)-5-amino-1,2-piperidinedicarboxylate | 2411590-87-7 |
1-Aminoethanesulfonic acid | 1636-31-3 |
5-chloro-4-iodo-1H-pyrazole | 27258-19-1 |
4-iodo-1H-pyrazole | 3469-69-0 |
Mannose Triflate | 92051-23-5 |
4-bromo-1H-pyrazole | 2075-45-8 |
Title | Therapeutic Area/Use | ODMF |
|---|---|---|
Prucalopride Succinate | Chronic Constipation | Available |
Trientine tetrahydrochloride | Wilsons disease | Available |
Gepirone Hydrochloride | Major depressive disorder | Available |
Chlorzoxzone | Muscle Relaxant | Available |
Trientine dihydrochloride | Wilsons disease | Available |
Benzocaine | Local anesthetic | Available |
Ubiquinol acetate | Dietary food supplement | Available |
Pyridoxamine dihydrochloride | Dietary food supplement | Available |
Safinamide | Parkinsons disease | Available |
Mosapride citrate | Gastroenterology / dyspepsia | Available |
Perampanel | Seizures | Available |
Ponesimode | Multiple sclerosis | Available |
Mavacamten | Obstructive hypertrophic cardiomyopathy | Available |
Seladelpar Lysine | Primary biliary cholangitis (PBC) | Available |
Ensifentrine | Chronic obstructive pulmonary disease (COPD) | Available |
Acoramidis Hydrochloride | Transthyretin amyloid cardiomyopathy (ATTR-CM) | Available |
Mospride citrate | Gastroesophageal reflux disease (GERD) | Available |
Tanimilast | Chronic obstructive pulmonary disease (COPD) | Available |
Givinostat | Duchenne muscular dystrophy (DMD) | Available |
Metclopramide | Gastrointestinal motility disorders | Available |
Cisapride monohydrate | Gastroesophageal reflux disease | Available |
Oxandrolone | Weight gain and muscle wasting | Available |
Haloperidol | Antipsychotic | Available |
Vitamin K2 (Menaquinone) | Food Supplement | Available |
Intermediate | CAS No | End Use (API) |
|---|---|---|
1-[4-(Methylthio)phenyl]ethanone | 1778-09-2 | Elafibranor |
2-Bromo-5-methoxybenzoic acid | 22921-68-2 | Daridorexant |
Methyl (2S)-2-methylpyrrolidine-2-carboxylate hydrochloride | 220060-08-2 | Daridorexant |
4-Chloro-3-methylbenzene-1,2-diamine hydrochloride | 1087743-89-2 | Daridorexant |
1,1-Dimethylethyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate | 163798-87-6 | Mavorixafor |
N1-[(8S)-5,6,7,8-Tetrahydro-8-quinolinyl]-1,4-butanediamine | 558447-10-2 | Mavorixafor |
1,1-Dimethylethyl 5-amino-1H-indazole-1-carboxylate | 129488-10-4 | Belumosudil mesylate |
Phenol, 3-(4-chloro-2-quinazolinyl)-, 1-acetate | 911417-24-8 | Belumosudil mesylate |
3,5-Dimethyl-4-hydroxybenzaldehyde | 2233-18-3 | Elafibranor |
(2E)-3-(4-Hydroxy-3,5-dimethylphenyl)-1-[4-(methylthio)phenyl]-2-propen-1-one | 923978-99-8 | Elafibranor |
4-Amino-3-Hydroxy benzoic acid | 2374-03-0 | Tafamidis & Tafamidis Meglumine |
3,3-Dimethylglutarimide | 1123-40-6 | Gepirone Hydrochloride |
5-(Pyridin-2-yl)-1,2-dihydropyridin-2-one | 381233-78-9 | Perampanel |
1-Phenyl-5-pyridin-2-ylpyridin-2-one | 381725-50-4 | Perampanel |
5′-Bromo-1′-phenyl[2,3′-bipyridin]-6′(1′H)-one | 381248-06-2 | Perampanel |
(4-Mercapto-2-methylphenoxy)acetic acid ethyl ester | 343322-82-7 | Seladelper Lysine |
Ethyl 2-(4-(Chlorosulfonyl)-2-Methylphenoxy) acetate | 91427-62-2 | Seladelper Lysine |
7-Dihydro-9,10-dimethoxy-2-[(2,4,6- trimethylphenyl)amino]-4H-pyrimido[6,1-a]isoquinolin- 4-one | 76536-66-8 | Ensifentrine |
3-(2-Aminoethyl)-2,3,6,7-tetrahydro-9,10-dimethoxy-2-[(2,4,6-trimethylphenyl)imino]-4H-pyrimido[6,1-a]isoquinolin-4-one | 298680-39-4 | Ensifentrine |
Methyl 4-fluoro-3-hydroxybenzoate | 214822-96-5 | Acoramidis Hydrochloride |
Methyl 3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluorobenzoate | 2167368-32-1 | Acoramidis Hydrochloride |
4-(3-Bromopropyl)-3,5-dimethyl-1H-pyrazole | 2167368-32-1 | Acoramidis Hydrochloride |
3,5-Dichloro-4-methylpyridine | 100868-46-0 | Tanimilast |
3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzaldehyde | 151103-09-2 | Tanimilast |
3-(Cyclopropylmethoxy)-4-(methylsulfonamido)benzoic acid | 1702375-12-9 | Tanimilast |
(6-((Diethylamino)methyl)naphthalen-2-yl)methanol | 1429441-33-7 | Givinostat |
4-(6-diethylaminomethyl-naphtalen-2-ylmethoxycarbonylamino)-benzoic acid | 199657-47-1 | Givinostat |
Tetrabenzyl-voglibose | 115250-39-0 | Voglibose |
4-Amino-5-chloro-2-ethoxy benzoic acid | 108282-38-8 | Mosapride citrate |
2-Aminomethy-4-(4-fluorobenzyl)morpholine | 112914-13-3 | Mosapride citrate |
5,6-Dichloro-1,3-dihydro-benzoimidazol-2-one | 2033-29-6 | Maribavir |
2-bromo-5,6-dichloro-1H-benzimidazole | 142356-40-9 | Maribavir |
4,5-Dichloro-1,2-benzenediamine | 5348-42-5 | Maribavir |
(2Z)-3-(2-Methylphenyl)-2-(propylimino)-4-thiazolidinone | 854107-53-2 | Ponesimod |
4-Thiazolidinone, 5-[(3-chloro-4-hydroxyphenyl)methylene]-3-(2-methylphenyl)-2-(propylimino)-, (2Z,5Z) | 1029435-58-2 | Ponesimod |
Ethyl (2,6-dimethylphenyl)glycinate | 2371-25-7 | Amenamevir |
4-(1,2,4-oxadiazol-3-yl)Benzenamine | 59908-70-2 | Amenamevir |
5-bromo-4-methoxy-2-methylbenzoic acid | 875245-69-5 | Luseogliflozin |
1-bromo-5-(4-ethoxybenzyl)-2-methoxy-4-methylbenzene | 898538-39-1 | Luseogliflozin |
Isopropylurea | 691-60-1 | Mavacamten |
1-Isopropylpyrimidine-2,4,6(1H,3H,5H)-trione | 69998-14-7 | Mavacamten |
6-Chloro-3-isopropylpyrimidine-2,4(1H,3H)-dione | 887581-47-7 | Mavacamten |
N-(2-Bromo-5-methoxyphenyl)acetamide | 123027-99-6 | Elacestrant |
7-(Benzyloxy)-3-bromo-1,2-dihydronaphthalene | 722536-73-4 | Elacestrant |
1,1'-Biphenyl]-4-carboxylic acid, 3'-bromo-4'-hydroxy-, ethyl ester | 895542-84-4 | Trifarotene |
Ethyl 4′-[2-(acetyloxy)ethoxy]-3′-bromo[1,1′-biphenyl]-4-carboxylate | 895542-96-8 | Trifarotene |
2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene | 1034305-17-3 | Ipragliflozin |
5'-Fluoro-2'-iodoacetophenone | 914225-70-0 | Lorlatinib |
N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAc) - Salcaprozate sodium | 203787-91-1 | Semaglutide |
3-Hydroxy-4-nitrobenzoic acid | 619-14-7 | Tafamidis & Tafamidis Meglumine |
1-(3-methoxypropyl)piperidin-4-amine | 179474-79-4 | Prucalopride Succinate |
4-Amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid | 123654-26-2 | Prucalopride Succinate |
Methyl 4-(acetylamino)-3-bromo-2-(2-bromoethoxy)-5-chlorobenzoate | 748788-39-8 | Prucalopride Succinate |
Methyl 4-acetamido-3-bromo-5-chloro-2-hydroxybenzoate | 232941-14-9 | Prucalopride Succinate |
Intermediate Name | CAS No |
|---|---|
3-Bromo-5-tertbutyl phenyl boronic acid | 1373881-94-7 |
Dimethylphosphoramidic dichloride | 677-43-0 |
N-1,3-Benzodioxol-5-yl-2,2,2-trifluoroacetamide | 85575-56-0 |
5-Amino-1-methyl-2-oxoindoline | 20870-91-1 |
4-(4-Nitrophenoxy)aniline | 6149-33-3 |
Cryptand 222 (Kryptofix 222) | 23978-09-8 |
1-(1,1-Dimethylethyl) 2-ethyl (2R,5S)-5-amino-1,2-piperidinedicarboxylate | 2411590-87-7 |
1-Aminoethanesulfonic acid | 1636-31-3 |
5-chloro-4-iodo-1H-pyrazole | 27258-19-1 |
4-iodo-1H-pyrazole | 3469-69-0 |
Mannose Triflate | 92051-23-5 |
4-bromo-1H-pyrazole | 2075-45-8 |
Title | Therapeutic Area/Use | ODMF |
|---|---|---|
Prucalopride Succinate | Chronic Constipation | Available |
Trientine tetrahydrochloride | Wilsons disease | Available |
Gepirone Hydrochloride | Major depressive disorder | Available |
Chlorzoxzone | Muscle Relaxant | Available |
Trientine dihydrochloride | Wilsons disease | Available |
Benzocaine | Local anesthetic | Available |
Ubiquinol acetate | Dietary food supplement | Available |
Pyridoxamine dihydrochloride | Dietary food supplement | Available |
Safinamide | Parkinsons disease | Available |
Mosapride citrate | Gastroenterology / dyspepsia | Available |
Perampanel | Seizures | Available |
Ponesimode | Multiple sclerosis | Available |
Mavacamten | Obstructive hypertrophic cardiomyopathy | Available |
Seladelpar Lysine | Primary biliary cholangitis (PBC) | Available |
Ensifentrine | Chronic obstructive pulmonary disease (COPD) | Available |
Acoramidis Hydrochloride | Transthyretin amyloid cardiomyopathy (ATTR-CM) | Available |
Mospride citrate | Gastroesophageal reflux disease (GERD) | Available |
Tanimilast | Chronic obstructive pulmonary disease (COPD) | Available |
Givinostat | Duchenne muscular dystrophy (DMD) | Available |
Metclopramide | Gastrointestinal motility disorders | Available |
Cisapride monohydrate | Gastroesophageal reflux disease | Available |
Oxandrolone | Weight gain and muscle wasting | Available |
Haloperidol | Antipsychotic | Available |
Vitamin K2 (Menaquinone) | Food Supplement | Available |
Intermediate | CAS No | End Use (API) |
|---|---|---|
1-[4-(Methylthio)phenyl]ethanone | 1778-09-2 | Elafibranor |
2-Bromo-5-methoxybenzoic acid | 22921-68-2 | Daridorexant |
Methyl (2S)-2-methylpyrrolidine-2-carboxylate hydrochloride | 220060-08-2 | Daridorexant |
4-Chloro-3-methylbenzene-1,2-diamine hydrochloride | 1087743-89-2 | Daridorexant |
1,1-Dimethylethyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate | 163798-87-6 | Mavorixafor |
N1-[(8S)-5,6,7,8-Tetrahydro-8-quinolinyl]-1,4-butanediamine | 558447-10-2 | Mavorixafor |
1,1-Dimethylethyl 5-amino-1H-indazole-1-carboxylate | 129488-10-4 | Belumosudil mesylate |
Phenol, 3-(4-chloro-2-quinazolinyl)-, 1-acetate | 911417-24-8 | Belumosudil mesylate |
3,5-Dimethyl-4-hydroxybenzaldehyde | 2233-18-3 | Elafibranor |
(2E)-3-(4-Hydroxy-3,5-dimethylphenyl)-1-[4-(methylthio)phenyl]-2-propen-1-one | 923978-99-8 | Elafibranor |
4-Amino-3-Hydroxy benzoic acid | 2374-03-0 | Tafamidis & Tafamidis Meglumine |
3,3-Dimethylglutarimide | 1123-40-6 | Gepirone Hydrochloride |
5-(Pyridin-2-yl)-1,2-dihydropyridin-2-one | 381233-78-9 | Perampanel |
1-Phenyl-5-pyridin-2-ylpyridin-2-one | 381725-50-4 | Perampanel |
5′-Bromo-1′-phenyl[2,3′-bipyridin]-6′(1′H)-one | 381248-06-2 | Perampanel |
(4-Mercapto-2-methylphenoxy)acetic acid ethyl ester | 343322-82-7 | Seladelper Lysine |
Ethyl 2-(4-(Chlorosulfonyl)-2-Methylphenoxy) acetate | 91427-62-2 | Seladelper Lysine |
7-Dihydro-9,10-dimethoxy-2-[(2,4,6- trimethylphenyl)amino]-4H-pyrimido[6,1-a]isoquinolin- 4-one | 76536-66-8 | Ensifentrine |
3-(2-Aminoethyl)-2,3,6,7-tetrahydro-9,10-dimethoxy-2-[(2,4,6-trimethylphenyl)imino]-4H-pyrimido[6,1-a]isoquinolin-4-one | 298680-39-4 | Ensifentrine |
Methyl 4-fluoro-3-hydroxybenzoate | 214822-96-5 | Acoramidis Hydrochloride |
Methyl 3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluorobenzoate | 2167368-32-1 | Acoramidis Hydrochloride |
4-(3-Bromopropyl)-3,5-dimethyl-1H-pyrazole | 2167368-32-1 | Acoramidis Hydrochloride |
3,5-Dichloro-4-methylpyridine | 100868-46-0 | Tanimilast |
3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzaldehyde | 151103-09-2 | Tanimilast |
3-(Cyclopropylmethoxy)-4-(methylsulfonamido)benzoic acid | 1702375-12-9 | Tanimilast |
(6-((Diethylamino)methyl)naphthalen-2-yl)methanol | 1429441-33-7 | Givinostat |
4-(6-diethylaminomethyl-naphtalen-2-ylmethoxycarbonylamino)-benzoic acid | 199657-47-1 | Givinostat |
Tetrabenzyl-voglibose | 115250-39-0 | Voglibose |
4-Amino-5-chloro-2-ethoxy benzoic acid | 108282-38-8 | Mosapride citrate |
2-Aminomethy-4-(4-fluorobenzyl)morpholine | 112914-13-3 | Mosapride citrate |
5,6-Dichloro-1,3-dihydro-benzoimidazol-2-one | 2033-29-6 | Maribavir |
2-bromo-5,6-dichloro-1H-benzimidazole | 142356-40-9 | Maribavir |
4,5-Dichloro-1,2-benzenediamine | 5348-42-5 | Maribavir |
(2Z)-3-(2-Methylphenyl)-2-(propylimino)-4-thiazolidinone | 854107-53-2 | Ponesimod |
4-Thiazolidinone, 5-[(3-chloro-4-hydroxyphenyl)methylene]-3-(2-methylphenyl)-2-(propylimino)-, (2Z,5Z) | 1029435-58-2 | Ponesimod |
Ethyl (2,6-dimethylphenyl)glycinate | 2371-25-7 | Amenamevir |
4-(1,2,4-oxadiazol-3-yl)Benzenamine | 59908-70-2 | Amenamevir |
5-bromo-4-methoxy-2-methylbenzoic acid | 875245-69-5 | Luseogliflozin |
1-bromo-5-(4-ethoxybenzyl)-2-methoxy-4-methylbenzene | 898538-39-1 | Luseogliflozin |
Isopropylurea | 691-60-1 | Mavacamten |
1-Isopropylpyrimidine-2,4,6(1H,3H,5H)-trione | 69998-14-7 | Mavacamten |
6-Chloro-3-isopropylpyrimidine-2,4(1H,3H)-dione | 887581-47-7 | Mavacamten |
N-(2-Bromo-5-methoxyphenyl)acetamide | 123027-99-6 | Elacestrant |
7-(Benzyloxy)-3-bromo-1,2-dihydronaphthalene | 722536-73-4 | Elacestrant |
1,1'-Biphenyl]-4-carboxylic acid, 3'-bromo-4'-hydroxy-, ethyl ester | 895542-84-4 | Trifarotene |
Ethyl 4′-[2-(acetyloxy)ethoxy]-3′-bromo[1,1′-biphenyl]-4-carboxylate | 895542-96-8 | Trifarotene |
2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene | 1034305-17-3 | Ipragliflozin |
5'-Fluoro-2'-iodoacetophenone | 914225-70-0 | Lorlatinib |
N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAc) - Salcaprozate sodium | 203787-91-1 | Semaglutide |
3-Hydroxy-4-nitrobenzoic acid | 619-14-7 | Tafamidis & Tafamidis Meglumine |
1-(3-methoxypropyl)piperidin-4-amine | 179474-79-4 | Prucalopride Succinate |
4-Amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid | 123654-26-2 | Prucalopride Succinate |
Methyl 4-(acetylamino)-3-bromo-2-(2-bromoethoxy)-5-chlorobenzoate | 748788-39-8 | Prucalopride Succinate |
Methyl 4-acetamido-3-bromo-5-chloro-2-hydroxybenzoate | 232941-14-9 | Prucalopride Succinate |
To receive price and delivery information on larger quantities, please complete the form below and we will respond promptly.
Your request for quote will also be accepted by e-mail at info@erythropharma.com or Fax: +91 40 2372 1063.